Both in Biotechnology
Taysha Gene Therapies vs Vir Biotechnology
Over the past year TSHA returned −12.9% and VIR returned +90.5%; their daily moves had a correlation of 0.49.
TSHA −12.9% VIR +90.5%Growth of $1, one year, split-adjusted
| Metric | TSHA | VIR |
|---|---|---|
| Price | $4.25 | $11.79 |
| Market cap | $1.38B | $2.00B |
| Today | 0.00% | +1.90% |
| 1 month | −14.8% | +10.7% |
| 6 months | −32.2% | +17.0% |
| Year to date | −22.7% | +95.5% |
| 1 year | −12.9% | +90.5% |
| Revenue growth (YoY) | −100.0% | +19582.5% |
| Gross margin | — | 100.0% |
| Net margin | — | 33.5% |
| P/E (TTM) | — | — |
| Price / sales | 252.5× | 6.6× |
| Net cash | $406.1M | $532.7M |
| Dividend yield | — | — |
| Volatility (60d) | 59.1% | 50.7% |
| Short % of float | 17.6% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).